Kunal Solanki

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 7

Top Topics

Anti Inflammatory

Cognitive Decline

Top Venues

Journal of biochemical and molecular toxicology

Chemical biology & drug design

Combinatorial chemistry & high throughput screening

Current pharmaceutical biotechnology

This page only lists publications with an associated author ORCID identifier.

Publications

Ahsas Goyal, Om Sikarwar, Aanchal Verma, Kunal Solanki, Neetu Agrawal, Nandini Dubey, Harlokesh Narayan Yadav
Unveiling myricetin's pharmacological potency: A comprehensive exploration of the molecular pathways with special focus on PI3K/AKT and Nrf2 signaling. Journal of biochemical and molecular toxicology 38 (6) (2024)
Aanchal Verma, Shobhit Chaudhary, Kunal Solanki, Ahsas Goyal, Harlokesh Narayan Yadav
Exendin-4: A potential therapeutic strategy for Alzheimer's disease and Parkinson's disease. Chemical biology & drug design 103 (1) (2024)
Ahsas Goyal, Vishwa Deep Singh, Kunal Solanki, Aanchal Verma
Revealing the Curative Possibilities: A Comprehensive Exploration of Caffeic Acid. Current pharmaceutical biotechnology (2024)
Aanchal Verma, Shobhit Chaudhary, Kunal Solanki, Ahsas Goyal, Harlokesh Narayan Yadav
Exendin-4: A potential therapeutic strategy for Alzheimer's disease and Parkinson's disease. Chemical biology & drug design 103 (1) (2024)
Ahsas Goyal, Om Sikarwar, Aanchal Verma, Kunal Solanki, Neetu Agrawal, Nandini Dubey, Harlokesh Narayan Yadav
Unveiling myricetin's pharmacological potency: A comprehensive exploration of the molecular pathways with special focus on PI3K/AKT and Nrf2 signaling. Journal of biochemical and molecular toxicology 38 (6) (2024)
Ahsas Goyal, Nandini Agrawal, Neetu Agrawal, Aanchal Verma, Kunal Solanki, Harlokesh Narayan Yadav
The Neuro-Healing Frontier: Alpha-Mangostin's Potential in Alzheimer's and Parkinson's Treatment. Combinatorial chemistry & high throughput screening (2024)
Ahsas Goyal, Kunal Solanki, Aanchal Verma
Luteolin: Nature's promising warrior against Alzheimer's and Parkinson's disease. Journal of biochemical and molecular toxicology (2023)